KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Shares Issued (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Shares Issued for 13 consecutive years, with -$18000.0 as the latest value for Q4 2025.

Quarterly Shares Issued rose 86.86% to -$18000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$109000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $10.2 million for FY2023, 3071.52% up from the prior year.
Shares Issued for Q4 2025 was -$18000.0 at Biolife Solutions, up from -$137000.0 in the prior quarter.
The five-year high for Shares Issued was $9.9 million in Q4 2023, with the low at -$1.0 million in Q4 2021.
Average Shares Issued over 5 years is $659312.5, with a median of $77500.0 recorded in 2023.
The sharpest move saw Shares Issued soared 61612.5% in 2023, then plummeted 101.39% in 2024.
Over 5 years, Shares Issued stood at -$1.0 million in 2021, then soared by 101.57% to $16000.0 in 2022, then skyrocketed by 61612.5% to $9.9 million in 2023, then crashed by 101.39% to -$137000.0 in 2024, then surged by 86.86% to -$18000.0 in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at -$18000.0, -$137000.0, and $46000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.